Blood Collection Market Size & Growth Forecast 2027–2036, By Segments (Method, Application, End-use, Product Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Blood Collection Market size was worth USD 11.06 Billion in 2026 and is expected to grow at 6.57% CAGR between 2027 and 2036, crossing USD 20.9 Billion by 2036. The industry revenue for 2027 is estimated at USD 11.68 Billion.

• Base Year Value (2026): USD 11.06 Billion
• CAGR (2027-2036): 6.57%
• Forecast Year Value (2036): USD 20.9 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Blood Collection Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held 38.23% in 2025, supported by established healthcare infrastructure, high diagnostic testing utilization, extensive laboratories, and demand for standardized collection solutions.
  • Asia Pacific is the fastest-growing region, driven by healthcare infrastructure expansion, greater diagnostic access, rising disease-related testing, and investments in laboratory capabilities.

• Segment Momentum:

  • Manual blood collection accounted for 56.29% of the market in 2025 due to its widespread use, established clinical protocols, accessibility, and suitability for routine diagnostic procedures across healthcare settings.
  • Diagnostic centers are the fastest-growing end-use segment as demand rises for specialized testing, faster turnaround times, preventive screening, and decentralized diagnostic services.

• Market Expansion Drivers:

  • Rising prevalence of chronic and infectious diseases increasing global blood testing volumes
  • Growing number of surgical procedures driving demand for efficient blood collection systems
  • Increasing adoption of automated blood collection devices improving diagnostic workflow efficiency

• Leading Market Participants:

  Key players in the blood collection market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Terumo Corporation (Japan), Thermo Fisher Scientific Inc. (United States), Siemens Healthineers AG (Germany), Haemonetics Corporation (United States), Greiner AG (Austria), Nipro Corporation (Japan), Sarstedt AG & Co. KG (Germany)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 11.06 Billion
  • 2027 Estimated Market Size: USD 11.68 Billion
  • Projected Market Size: USD 20.9 Billion by 2036
  • Growth Forecasts: 6.57% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Manual Blood Collection (Method) | Diagnostics (Application) | Hospitals and Clinics (End-use) | Venous (Product Type)
  • Emerging Opportunity Segment: Automated Blood Collection (Method) | Diagnostics (Application) | Diagnostic Centers (End-use) | Capillary (Product Type)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic and infectious diseases increasing global blood testing volumes

The increasing burden of chronic and infectious diseases is driving greater reliance on laboratory diagnostics for disease detection, monitoring, and treatment planning. The blood collection market growth is driven by expanding blood testing requirements across hospitals, diagnostic laboratories, and outpatient healthcare settings. Healthcare providers are performing more routine and specialized blood analyses to support timely clinical decision-making, increasing demand for reliable blood collection products and procedures.

Growing number of surgical procedures driving demand for efficient blood collection systems

The rising volume of surgical interventions is increasing the need for accurate preoperative, intraoperative, and postoperative laboratory assessments. The blood collection market will benefit from growing demand for efficient collection systems that facilitate safe sample acquisition and support rapid diagnostic testing throughout the patient care pathway. Medical facilities are prioritizing collection solutions that improve sample integrity, streamline clinical workflows, and reduce the risk of handling errors.

Increasing adoption of automated blood collection devices improving diagnostic workflow efficiency

Healthcare institutions are increasingly incorporating automated technologies to enhance laboratory productivity and improve patient experience during sample collection. The blood collection market growth is supported by wider adoption of automated blood collection devices that promote consistent sample quality, reduce manual variability, and optimize diagnostic workflows. These systems assist healthcare professionals by improving operational efficiency while supporting standardized collection practices across diverse clinical environments.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic and infectious diseases increasing global blood testing volumes	2%	High	North America, Asia Pacific	High	Near Term
Growing number of surgical procedures driving demand for efficient blood collection systems	1.8%	High	Europe, North America	High	Near Term
Increasing adoption of automated blood collection devices improving diagnostic workflow efficiency	1.5%	Moderate	Asia Pacific, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest share of the blood collection market at 38.23% in 2026, supported by well-established healthcare infrastructure, high utilization of diagnostic testing, and strong demand for reliable blood collection products across hospitals, laboratories, and outpatient care settings. The region's extensive network of clinical laboratories and healthcare facilities supports consistent demand for collection tubes, needles, blood bags, and related consumables. Growing emphasis on early disease detection, routine health screening, and laboratory-based diagnosis is further strengthening blood sample collection volumes. In addition, established quality standards and continued investments in healthcare technology encourage the adoption of efficient and standardized collection solutions.

Asia Pacific is anticipated to be the fastest-growing regional market, driven by expanding healthcare infrastructure, increasing access to diagnostic services, and rising awareness of preventive healthcare. The growing patient population and increasing prevalence of chronic and infectious diseases are encouraging greater use of laboratory testing, which in turn is creating sustained demand for blood collection products. Healthcare modernization across emerging economies is also improving the availability of hospitals, diagnostic laboratories, and specialized testing facilities. Government efforts to broaden healthcare access, together with rising investments in clinical infrastructure and laboratory capabilities, are expected to accelerate adoption across the region.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Method Segment Analysis: Manual Blood Collection (Largest Segment) vs Automated Blood Collection (Fastest-Growing Segment)

The blood collection market was led by the manual blood collection segment, which accounted for a 56.29% share in 2026. Manual collection methods remain widely used across healthcare settings due to their accessibility, established clinical protocols, and suitability for routine diagnostic procedures. Hospitals, clinics, and blood donation centers continue to rely on trained healthcare professionals to perform venipuncture efficiently, particularly in regions where healthcare infrastructure is already optimized around conventional collection practices. The familiarity and flexibility associated with manual procedures have helped maintain the segment’s dominant position.

Automated blood collection is emerging as the fastest-growing segment as healthcare providers increasingly prioritize operational efficiency, donor comfort, and sample quality. Automated systems enable greater precision in collecting targeted blood components while reducing variability associated with manual procedures. Rising demand for blood components in transfusion medicine, along with advancements in collection technologies that improve workflow and resource utilization, is accelerating adoption across specialized collection centers and modern healthcare facilities.

Application Segment Analysis: Diagnostics (Largest & Fastest-Growing Segment)

The diagnostics segment dominated the blood collection market with a 53.74% share in 2026 and also represented the fastest-growing application area. Blood samples are fundamental to diagnosing a broad range of medical conditions, supporting routine health assessments, disease detection, and treatment monitoring. The increasing prevalence of chronic and infectious diseases, combined with growing emphasis on preventive healthcare, has reinforced the importance of diagnostic testing worldwide. Continuous advancements in laboratory technologies and the expanding use of blood-based diagnostic procedures are further strengthening demand, enabling the segment to maintain both its leadership position and growth momentum.

End-use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Diagnostic Centers (Fastest-Growing Segment)

Hospitals and clinics held the largest share of the blood collection market at 40.07% in 2026. These facilities manage a substantial volume of patient testing, emergency care, surgical procedures, and routine health evaluations, creating consistent demand for blood collection services. Their integrated healthcare infrastructure and ability to provide comprehensive diagnostic and treatment services make them the primary setting for blood sample collection across diverse patient populations.

Diagnostic centers are witnessing the fastest growth due to the increasing preference for specialized testing services and the expansion of outpatient diagnostics. These centers offer dedicated laboratory capabilities, efficient turnaround times, and access to a broad range of testing procedures. Growing awareness of preventive screening, rising demand for diagnostic accuracy, and the continued decentralization of healthcare services are contributing to the rapid expansion of diagnostic centers within the market.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Method	Manual Blood Collection, Automated Blood Collection	Manual Blood Collection	Automated Blood Collection
Application	Diagnostics, Treatment, Research	Diagnostics	Diagnostics
End-use	Hospitals and Clinics, Diagnostic Centers, Blood Banks, Academic and Research Institutes	Hospitals and Clinics	Diagnostic Centers
Product Type	Venous, Capillary	Venous	Capillary

Competitive Landscape and Market Positioning

Leading companies in the blood collection market:

1. Becton Dickinson and Company (United States)
2. Abbott Laboratories (United States)
3. F. Hoffmann-La Roche AG (Switzerland)
4. Terumo Corporation (Japan)
5. Thermo Fisher Scientific, Inc. (United States)
6. Siemens Healthineers AG (Germany)
7. Haemonetics Corporation (United States)
8. Greiner AG (Austria)
9. Nipro Corporation (Japan)
10. Sarstedt AG & Co. KG (Germany)

Healthcare providers are placing greater emphasis on specimen quality, workflow efficiency, and patient safety, prompting manufacturers to expand beyond individual collection devices toward integrated sample management solutions. Competitive differentiation is increasingly shaped by innovations that reduce collection errors, improve user ergonomics, and support seamless compatibility with automated laboratory workflows. Suppliers are also strengthening their presence through clinical training, standardized product portfolios, and dependable supply capabilities, making operational consistency and procedural reliability key factors in purchasing decisions across healthcare settings.

Industry Development/News

Company Name	Date	Key Development
Provacu	Jul-26	Provacu commissioned a fully compliant ISO Class 7 and Class 8 cleanroom manufacturing facility in the UAE. The infrastructure investment significantly enhances regional production capabilities for in vitro diagnostic products and medical consumables, specifically targeting blood collection and diagnostic-related devices.
Vitestro	Mar-26	Vitestro secured $70 million in a Series B funding round to scale its manufacturing infrastructure and accelerate the commercialization of its autonomous robotic blood collection technology. The capital injection supports global expansion strategies and U.S. market entry initiatives.
Neurogen Biomarking	Nov-25	Neurogen Biomarking entered into a strategic partnership with Tasso to integrate needle-free capillary blood collection technology into its home-based Alzheimer's testing framework. The collaboration expands remote diagnostic capabilities by utilizing minimally invasive patient-led sampling methods.
Quest Diagnostics	Aug-25	Quest Diagnostics completed the acquisition of Spectra Laboratories' clinical testing assets from Fresenius Medical Care. The transaction expands Quest's diagnostic testing capabilities and strengthens its core laboratory services portfolio within the clinical diagnostics ecosystem.
Tasso	Feb-25	Tasso launched the Tile-T20 cartridge alongside the wearable Tasso Mini push-button lancet system. The introduction expands the company's proprietary product portfolio of at-home dried blood spot collection devices tailored specifically for decentralized clinical trials and remote molecular diagnostics.
BD	Dec-24	BD and Babson Diagnostics expanded the commercial availability of their co-developed fingertip blood collection solution to urgent care clinics and physician practices. The strategic initiative scales geographic and operational distribution of minimally invasive diagnostic blood collection.
Kriya Medical Technologies	Sep-24	Kriya Medical Technologies launched the ICHOR Medical Molding System, a highly automated production system designed for blood collection tube manufacturing. The infrastructure investment establishes a planned annual capacity of 250 million tubes, strengthening domestic production resilience for medical consumables.
Platinum Equity	Aug-24	Platinum Equity finalized the acquisition of ASP Global, a specialized supplier of customized medical products. The strategic transaction expands the private equity firm's healthcare portfolio, integrating key clinical and laboratory medical consumables capabilities.
BD	Mar-24	BD introduced the Vacutainer UltraTouch Push Button Blood Collection Set in India, incorporating advanced needle design technologies to optimize patient comfort. The product launch broadens the company's regional medical device portfolio and establishes an expanded competitive footprint in the Indian market.
HemoFlow	Jan-24	HemoFlow launched its 500 Series blood scale and mixer devices in the United States alongside the complementary HemoVue cloud platform. The integrated technological solution enhances blood bank operational workflows by delivering real-time device connectivity and centralized data tracking.